Navigation Links
Intrexon Announces Third Quarter Financial Results
Date:11/7/2013

ed probiotics for the treatment of diseases of the oral cavity, throat, sinus and esophagus that will be designed to work orally rather than through the digestive system with a goal of increasing the probability of effective treatment outcomes.

In 2011, we entered into our first collaboration and have steadily increased the number over the past three years, entering into new agreements and expanding existing ECCs.  To date, we have entered into 17 such agreements and expansions with 14 different counterparties, of which 16 remain active.  We have 14 active ECCs, including one expansion, and two research collaborations that we anticipate could, if successful, become ECCs.  Under the ECCs, we are developing products in the fields of healthcare and food. In healthcare, our ECCs include programs in oncology, anti-infectives, antibiotics and tissue repair. In food, we are working to increase the productivity and nutritional value of salmon and other fish. We are also working to establish ECCs in the areas of energy and environmental sciences. 

Third Quarter 2013 Financial Results Compared to Prior Year PeriodTotal revenues were $6.1 million for the three months ended September 30, 2013 compared to $2.9 million for the three months ended September 30, 2012, an increase of $3.2 million, or 109.7%. The $3.1 million increase in collaboration revenue resulted primarily from the recognition of deferred revenue for upfront payments received from five collaborations signed by Intrexon between October 1, 2012 and September 30, 2013, as well as one milestone payment received in October 2012.  Revenues also increased as a result of research and development services the Company performed under these new agreements.  Research and development services revenue covered 28% and 12% of total operating expenses for the three months ended September 30, 2013 and 2012, respectively.

Research and development expenses were $10.8 million for t
'/>"/>

SOURCE Intrexon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
2. Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
3. Pro-Dex, Inc. Announces Fiscal 2014 First Quarter Financial Results Conference Call And Webcast
4. DURECT Announces Proposed Public Offering of Common Stock
5. Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting
6. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
8. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
9. PDL BioPharma Announces Third Quarter 2013 Financial Results
10. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
11. Heska Announces Financial Results for the Third Quarter of Fiscal 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , ... announced today that T. (Teo) Forcht Dagi ... the company,s Board of Directors. " Teo ... career in neurosurgery, medical innovation and venture capital," said ... extremely delighted to add his clinical, strategic, and entrepreneurial expertise ...
(Date:8/29/2014)... PITTSBURGH , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage ... at the Australian and New Zealand Forensic Science ... Forensic Sciences in Adelaide, Australia ... discussion concerning the advancements that hyperspectral imaging can ... Jeffrey Beckstead , Director of Product Development ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data Solutions ... new website design . The main website, along with ... the company,s new services and content relevant to the ... new streamlined design, viewers can now better understand how ... care practices and create a more visible platform about ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
... May 25 National Anesthesia Services, Inc. celebrates its 21st anniversary ... CRNA,s on both a locum tenens and permanent basis in hospitals, surgery ... , , ... back in 1989 when we first began," said president and owner ...
... Labeling changes will include new safety information , ... SILVER SPRING, Md. , May 25 The U.S. Food ... risk of fractures of the hip, wrist, and spine with high doses or long-term ... be changed to describe this possible increased risk. , ...
Cached Medicine Technology:National Anesthesia Services, Inc. Celebrates 21 Years of Dynamic Growth and Achievement 2FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 2FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 3
(Date:8/29/2014)... 29, 2014, 2 PM US Eastern Time)The current ... inject antibodies, commonly produced in animals, to neutralize ... from safety to difficulties in developing, producing and ... New research led by Charles Shoemaker, Ph.D., professor ... Health at the Cummings School of Veterinary Medicine ...
(Date:8/29/2014)... The microbiology testing sector is one of the ... is also the hugest challenge facing suppliers during these ... of AIDS – still the world’s key health threat ... opportunistic infections (OIs); bioterrorism threat; advancements in technologies for ... Although for certain infections the etiology remains a mystery, ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Prostate cancer ... good treatment decisions. This can lead to worse quality ... The study included 70 men, with a median age ... cancer. Poor understanding of the disease was associated ... less confidence that the treatment would be effective, the ...
(Date:8/29/2014)... 2014 Edvance360, a leading provider of ... online teaching, as well as 2011 winner and six-time-finalist ... Management System, announced that Brooke Education Services, Northwest Academy, ... Interactive Advertising Bureau of Canada (IAB Canada), StarSVCS, and ... are delighted to welcome each new client to the ...
(Date:8/29/2014)... is a U.S. Food and Drug Administration (FDA)-approved ... raloxifene is as effective at reducing fracture risk ... by suppressing bone loss. With the use of ... respectively), researchers carried out experiments at the U.S. ... at Argonne National Laboratory that revealed an additional ...
Breaking Medicine News(10 mins):Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2Health News:Edvance360 Continues to Experience Growth in Corporate, K-12, Health, and Non-Profit Sectors 2Health News:Revealing a novel mode of action for an osteoporosis drug 2
... 5k Walks Drive Home Importance of Awareness and Education ... an effort to raise money for The Kidney TRUST(TM) ... of chronic kidney disease (CKD) -- DaVita Inc., the ... that the 3rd annual "Kidney Awareness Time(TM)" Walk-a-thon (The ...
... - , , ANTHEM, Ariz., Dec. 29 ... its new web site at http://www.mychoicedentist.com and said ... , Arizona, area is proceeding successfully. "Arizona is the ... "We anticipate expanding this service to almost every major U.S. ...
... of Jinja, the second largest city in Uganda, ... with the Agatha Foundation Medical Center, approximately $1 ... be placed into the hands of doctors in ... treatment and care for thousands of people. The ...
... Solution. , ... Panama City, FL ... data automation solutions for healthcare providers, today announced that it ... Center (JRMC). Located in Pine Bluff, Arkansas, JRMC is a ...
... Facilitate and Boost Patient Admissions for Family-Owned Long-Term Healthcare Provider. ... ... Placement Systems announced today that healthcare provider Park Avenue Nursing and ... Web-based Referral Management System long-term care software to manage ...
... to carry out the high-tech cosmetic leg lengthening procedure in 2001. Fitbone ... Asia and costs around US $42,000 per telescope nail in Singapore. ... ... a method of leg lengthening for those with congenital growth abnormalities or ...
Cached Medicine News:Health News:Thousands of DaVita Teammates Raise Over $100,000 for CKD Programs 2Health News:Thousands of DaVita Teammates Raise Over $100,000 for CKD Programs 3Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:American-Based NGO Sends Emergency Medical Relief to Uganda 2Health News:Jefferson Regional Medical Center Selects iSirona DeviceConX for Medical Device Integration 2Health News:Park Avenue Nursing and Rehabilitation Center Selects PatientPlacement.com Web-based Long-Term Care Software to Automate Admissions and Boost Census Performance 2Health News:Park Avenue Nursing and Rehabilitation Center Selects PatientPlacement.com Web-based Long-Term Care Software to Automate Admissions and Boost Census Performance 3Health News:Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller 2Health News:Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: